Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.16 USD
Change Today +0.16 / 1.60%
Volume 2.3M
ACHN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gautam Shah Ph.D.

Chief Regulatory Officer and Executive Vice President, Achillion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

57$883,243
As of Fiscal Year 2013

Background*

Dr. Gautam Shah, Ph.D. serves as the Chief Regulatory Officer of Achillion Pharmaceuticals, Inc. and its Executive Vice President since May 2012 and served its Chief Compliance Officer since September 2006. Dr. Shah served as Senior Vice President and Vice President of Regulatory Affairs at Achillion Pharmaceuticals, Inc. since September 2006 and May 2004 respectively. He has over sixteen years of pharmaceutical industry experience and has coordinated regulatory submissions ...

Read Full Background

Corporate Headquarters*

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-624-7000
Fax: 203-624-7003

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Doctorate
University of Illinois-Urbana-Champaign
Bachelor's Degree
University of Illinois-Urbana-Champaign
Master's Degree
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

Salary$334,400
Total Annual Compensation$334,400

Stock Options*

All Other Compensation$7,992
Exercised Options26,965
Exercised Options Value$141,792
Exercisable Options160,438
Exercisable Options Value$10,673
Unexercisable Options413,875
Unexercisable Options Value$70,340
Total Value of Options$222,804
Total Number of Options601,278

Total Compensation*

Total Annual Cash Compensation$418,468
Total Short Term Compensation$334,400
Other Long Term Compensation$7,992
Total Calculated Compensation$883,243
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $10.16 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$340.0K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.